Beta B1-crystallin: Identification of a candidate ciliary body uveitis antigen

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 1, 2003, Pages 203-209

  Stempel, David ^a   Sandusky, Hallie ^a   Lampi, Kirsten ^b   Cilluffo, Marianne ^a   Horwitz, Joe ^a   Braun, Jonathan ^a   Goodglick, Lee ^a   Gordon, Lynn K ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA B1 CRYSTALLIN; BETA CRYSTALLIN; BIOLOGICAL MARKER; MONOCLONAL ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; AUTOANTIGEN; MESSENGER RNA;

ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; CILIARY BODY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; HUMAN TISSUE; LENS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN TARGETING; PROTEOMICS; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UVEITIS; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANIMAL; CATTLE; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; IRIDOCYCLITIS; METABOLISM; MOLECULAR GENETICS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; AUTOANTIGENS; BETA-CRYSTALLIN B CHAIN; BLOTTING, WESTERN; CATTLE; CILIARY BODY; HUMANS; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; UVEITIS, ANTERIOR;

EID: 0037207478     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.01-1261     Document Type: Article

References (53)

1. Xu H, Rizzo LV, Silver PB, Caspi RR. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell Immunol 1997;178:69-78.
2. Caspi RR, Silver PB, Chan CC, et al. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. J Immunol 1996;157:2668-2675.
3. Singh VK, Mehrotra S, Agarwal SS. The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy. Immunol Res. 1999;20:147-161.
4. Pugliese A, Eisenbarth GS. Type I diabetes mellitus: lessons for human autoimmunity. J Lab Clin Med. 1992;120:363-366.
5. van Pesch V, Jadoul M, Lefebvre C, et al. Clinical significance of antiproteinase 3 antibody positivity in cANCA-positive patients. Clin Rheumatol. 1999;18:279-282.
6. Shanahan F, Duerr RH, Rotter JI, et al. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology. 1992;103:456-461.
7. Vasiliauskas EA, Plevy SE, Landers CJ, et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology. 1996;110:1810-1819.
8. Taylor KD, Plevy SE, Yang H, et al. ANCA pattern and LTA haplo-type relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease. Gastroenterology. 2001;120:1347-1355.
9. Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis [see comments]. Arthritis Rheum. 1993;36:365-371.
10. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Bull Rheum Dis. 1998;47:5-8.
11. Mor F, Weinberger A, Cohen IR. Identification of alpha-tropomyosin as a target self-antigen in Behcet's Syndrome. Eur J Immunol. 2002;32:356-365.
12. Yang H, Rotter JI, Toyoda H, et al. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest. 1993;92:1080-1084.
13. Gordon LK, Eggena M, Holland GN, Weisz JM, Braun J. pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis. J Clin Immunol 1998;18:264-271.
14. Eggena M, Targan SR, Iwanczyk L, Vidrich A, Gordon LK, Braun J. Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis. J Immunol. 1996;156:4005-4011.
15. Gordon LK, Eggena M, Targan SR, Braun J. Definition of ocular antigens in ciliary body and retinal ganglion cells by the marker antibody pANCA. Invest Ophthalmol Vis Sci. 1999;40:1250-1255.
16. Gordon LK, Eggena M, Targan SR, Braun J. Mast cell and neuroendocrine cytoplasmic autoantigen(s) detected by monoclonal pANCA antibodies. Clin Immunol. 2000;94:42-50.
17. Cohavy O, Harth G, Horwitz M, et al. Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease. Infect Immun. 1999;67:6510-6517.
18. Cohavy O, Bruckner D, Gordon LK, et al. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun. 2000;68:1542-1548.
19. Bora NS, Kim MC, Kabeer NH, et al. Experimental autoimmune anterior uveitis: induction with melanin-associated antigen from the iris and ciliary body. Invest Ophthalmol Vis Sci. 1995;36:1056-1066.
20. McMenamin PG, Crewe J, Kijlstra A. Resident and infiltrating cells in the rat iris during the early stages of experimental melanin protein-induced uveitis (EMIU). Ocul Immunol Inflamm. 1997;5:223-233.
21. Prendergast RA, Iliff CE, Coskuncan NM, et al. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci. 1998;39:754-762.
22. Forrester JV, Liversidge J, Dick A, et al. What determines the site of inflammation in uveitis and chorioretinitis? Eye. 1997;11:162-166.
23. Smith JR, Hart PH, Williams KA. Basic pathogenic mechanisms operating in experimental models of acute anterior uveitis. Immunol Cell Biol. 1998;76:497-512.
24. Sandusky H, Cilluffo M, Braun J, Gordon LK. Ocular pANCA antigens are expressed in nonpigmented ciliary body epithelium and are conserved in multiple mammalian species. Ocul Immunol Inflamm. 2001;9:25-34.
25. Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol. 1999;128:733-738.
26. Cilluffo MC, Fain MJ, Fain GL. Tissue culture of rabbit ciliary body epithelial cells on permeable supports. Exp Eye Res. 1993;57:513-526.
27. Fain GL, Cilluffo MC, Fain MJ, Lee DA. Isolation of non-pigmented epithelial cells from rabbit ciliary body. Invest Ophthalmol Vis Sci. 1988;29:817-821.
28. Guillevin L, Lhote F, Gherardi R. The spectrum and treatment of virus-associated vasculitides. Curr Opin Rheumatol. 1997;9:31-36.
29. Ropper AH, Gorson KC. Neuropathies associated with paraproteinemia. N Engl J Med. 1998;338:1601-1607.
30. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
31. Wadehra M, Braun J, Goodglick L. One-step RT-PCR for screening microdissected tissue. Biotechniques. 2002;32:242-248.
32. Lampi KJ, Ma Z, Hanson SR, et al. Age-related changes in human lens crystallins identified by two-dimensional electrophoresis and mass spectrometry. Exp Eye Res. 1998;67:31-43.
33. Shih M, Lampi KJ, Shearer TR, David LL. Cleavage of beta crystallins during maturation of bovine lens. Mol Vis. 1998;4:4.
34. David LL, Lampi KJ, Lund AL, Smith JB. The sequence of human betaB1-crystallin cDNA allows mass spectrometric detection of betaB 1 protein missing portions of its N-terminal extension. J Biol Chem. 1996;271:4273-4279.
35. Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80:844-848
36. Lindstrom JM. Acetylcholine receptors and myasthenia. Muscle Nerve. 2000;23:453-477.
37. Vincent A, Lily O, Palace J. Pathogenic autoantibodies to neuronal proteins in neurological disorders. J Neuroimmunol. 1999;100:169-180.
38. Butler TL, McMenamin PG. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci. 1996;37:2195-2210.
39. Gordon YJ. The evolution of antiviral therapy for external ocular viral infections over twenty-five years. Cornea. 2000;19:673-680.
40. Feng J, Smith DL, Smith JB. Human lens beta-crystallin solubility. J Biol Chem. 2000;275:11585-11590.
41. Ibaraki N, Lin LR, Dang L, et al. Anti-beta-crystallin antibodies (mouse) or sera from humans with age-related cataract are cytotoxic for lens epithelial cells in culture. Exp Eye Res. 1997;64:229-238.
42. Oertel MF, May CA, Bloemendal H, Lütjen-Drecoll E. Alpha-B-crystallin expression in tissues derived from different species in different age groups. Ophthalmologica. 2000;214:13-23.
43. Posner M, Kantorow M, Horwitz J. Cloning, sequencing and differential expression of alphaB-crystallin in the zebrafish, Danio rerio. Biochim Biophys Acta. 1999;1447:271-277.
44. Robinson ML, Overbeek PA. Differential expression of alpha A- and alpha B-crystallin during murine ocular development. Invest Ophthalmol Vis Sci. 1996;37:2276-2284.
45. Magabo KS, Horwitz J, Piatigorsky J, Kantorow M. Expression of betaB(2)-crystallin mRNA and protein in retina, brain, and testis. Invest Ophthalmol Vis Sci. 2000;41:3056-3060.
46. Head MW, Peter A, Clayton RM. Evidence for the extralenticular expression of members of the beta-crystallin gene family in the chick and a comparison with delta-crystallin during differentiation and transdifferentiation. Differentiation. 1991;48:147-156.
47. Clayton RM, Truman DE. The structure and cross-reactivity of chick lens proteins. J Physiol. 1968;198:72-73.
48. Dirks RP, Van Genesen ST, Kruse JJ, Jorissen L, Lubsen NH. Extralenticular expression of the rodent betaB2-crystallin gene [letter]. Exp Eye Res. 1998;66:267-269.
49. Hutnik CM, Nichols BD. Cataracts in systemic diseases and syndromes. Curr Opin Ophthalmol. 1998;9:14-19.
50. Singh DP, Guru SC, Kikuchi T, Abe T, Shinohara T. Autoantibodies against beta-crystallins induce lens epithelial cell damage and cataract formation in mice. J Immunol. 1995;155:993-999.
51. Luntz MH. Anti-uveal and anti-lens antibodies in uveitis and their significance. Exp Eye Res. 1968;7:561-569.
52. Patel M, Shine B, Murray PI. Antilens antibodies in cataract and inflammatory eye disease: an evaluation of a new technique. Int Ophthalmol. 1990;14:97-100.
53. Merck KB, Haard-Hoekman WA, Cruysberg JR, Bloemendal H, de Jong WW. Characterization of anti-crystallin autoantibodies in patients with cataract. Mol Biol Rep. 1993;17:93-99.